Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03228186
Title Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center

lung non-small cell carcinoma


Docetaxel + MLN4924

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.